Haiyan Xu

The superior efficacy of anti-PD-1/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype and increased immunogenicity

Chengming Liu, Sufei Zheng, Runsen Jin et al. · Cancer Letters · 2019 · 284 citations · Full text

Medicine, Immunology, Oncology +17

Delay in Feedback Repression by Cryptochrome 1 Is Required for Circadian Clock Function

Maki Ukai‐Tadenuma, Rikuhiro G. Yamada, Haiyan Xu et al. · Cell · 2011 · 271 citations · Full text

Life Sciences, Genetics, Molecular Biology +16

Deep Whole-Genome Sequencing of 100 Southeast Asian Malays

Lai-Ping Wong, Rick Twee‐Hee Ong, Wan-Ting Poh et al. · The American Journal of Human Genetics · 2013 · 198 citations · Full text

Life Sciences, Genetics, Molecular Genetics +10

<i>KRAS</i> ‐G12D mutation drives immune suppression and the primary resistance of anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer

Chengming Liu, Sufei Zheng, Zhanyu Wang et al. · Cancer Communications · 2022 · 175 citations · Full text

Medicine, Immunology, Oncology +17

Cryptochrome 1 regulates the circadian clock through dynamic interactions with the BMAL1 C terminus

Haiyan Xu, Chelsea L. Gustafson, Patrick J. Sammons et al. · Nature Structural & Molecular Biology · 2015 · 170 citations · Full text

Life Sciences, Genetics, Molecular Biology +16